GlassScriptPhysician profile
Kurt A Anderson
NPI 1548251085
$1,314.17
in general payments reported to CMS, 2019-2025
10 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $158 · 2021: $155 · 2022: $131 · 2023: $267 · 2024: $131 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $261.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $783.67 | 2019-2024 | Procare |
| Stryker Corporation | $223.82 | 2023-2025 | Pangea, Evolve Proline, Evolve |
| Axogen | $84.49 | 2023 | Avance Nerve Graft |
| Endo Pharmaceuticals INC. | $53.37 | 2019-2021 | |
| Dexcom, INC. | $46.38 | 2025 | Dexcom G6 Transmitter |
| Sunovion Pharmaceuticals INC. | $36.60 | 2019 | |
| Amgen INC. | $29.53 | 2025 | Krystexxa |
| Pacira Therapeutics, INC. | $20.99 | 2019 | |
| Endo USA, INC. | $18.45 | 2025 | Xiaflex |
| Invictus Surgical Incorporated | $16.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.